methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate

C21H21N7O3S2 — CID 87403935

IUPACmethyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate
SMILESCOC(=O)N1CCN(CC(=O)Nc2nc3ccc(Sc4cnc5ncccn45)cc3s2)CC1
InChIInChI=1S/C21H21N7O3S2/c1-31-21(30)27-9-7-26(8-10-27)13-17(29)25-20-24-15-4-3-14(11-16(15)33-20)32-18-12-23-19-22-5-2-6-28(18)19/h2-6,11-12H,7-10,13H2,1H3,(H,24,25,29)
InChIKeyWOFSOBAFASZARS-UHFFFAOYSA-N
MW483.58 g/mol
LogP2.81
Rot. Bonds5

About methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate

methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate (PubChem CID 87403935) has the molecular formula C21H21N7O3S2 and a molecular weight of 483.58 g/mol. Its IUPAC name is methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate.

Molecular Properties

Compound Namemethyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate
PubChem CID87403935
Molecular FormulaC21H21N7O3S2
Molecular Weight483.58 g/mol
Exact Mass483.11
IUPAC Namemethyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate
SMILESCOC(=O)N1CCN(CC(=O)Nc2nc3ccc(Sc4cnc5ncccn45)cc3s2)CC1
InChIInChI=1S/C21H21N7O3S2/c1-31-21(30)27-9-7-26(8-10-27)13-17(29)25-20-24-15-4-3-14(11-16(15)33-20)32-18-12-23-19-22-5-2-6-28(18)19/h2-6,11-12H,7-10,13H2,1H3,(H,24,25,29)
InChIKeyWOFSOBAFASZARS-UHFFFAOYSA-N
XLogP2.81
TPSA104.96 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds5
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500483.58
LogP ≤ 52.81
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Analyze methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate?
The IUPAC name of methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate (CID 87403935) is methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate.
What is the SMILES notation for methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate?
The canonical SMILES for methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate is COC(=O)N1CCN(CC(=O)Nc2nc3ccc(Sc4cnc5ncccn45)cc3s2)CC1.
What is the InChIKey of methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate?
The InChIKey is WOFSOBAFASZARS-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H21N7O3S2/c1-31-21(30)27-9-7-26(8-10-27)13-17(29)25-20-24-15-4-3-14(11-16(15)33-20)32-18-12-23-19-22-5-2-6-28(18)19/h2-6,11-12H,7-10,13H2,1H3,(H,24,25,29).
What are the key properties of methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate?
methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate has a molecular weight of 483.58 g/mol, XLogP of 2.81, 5 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for methyl 4-[2-[(6-imidazo[1,2-a]pyrimidin-3-ylsulfanyl-1,3-benzothiazol-2-yl)amino]-2-oxoethyl]piperazine-1-carboxylate is sourced from PubChem (CID 87403935), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).